DE60301351D1 - Pharmazeutische Desmopressin-Zubereitung als feste Darreichungsform und Methode zu ihrer Herstellung - Google Patents

Pharmazeutische Desmopressin-Zubereitung als feste Darreichungsform und Methode zu ihrer Herstellung

Info

Publication number
DE60301351D1
DE60301351D1 DE60301351T DE60301351T DE60301351D1 DE 60301351 D1 DE60301351 D1 DE 60301351D1 DE 60301351 T DE60301351 T DE 60301351T DE 60301351 T DE60301351 T DE 60301351T DE 60301351 D1 DE60301351 D1 DE 60301351D1
Authority
DE
Germany
Prior art keywords
preparation
dosage form
desmopressin
solid dosage
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60301351T
Other languages
English (en)
Other versions
DE60301351T2 (de
Inventor
Hakan Lomryd
Helena Nicklasson
Lars-Erik Olsson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ferring BV
Original Assignee
Ferring BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34117527&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE60301351(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ferring BV filed Critical Ferring BV
Publication of DE60301351D1 publication Critical patent/DE60301351D1/de
Application granted granted Critical
Publication of DE60301351T2 publication Critical patent/DE60301351T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/095—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE60301351T 2003-07-25 2003-07-25 Pharmazeutische Desmopressin-Zubereitung als feste Darreichungsform und Methode zu ihrer Herstellung Expired - Lifetime DE60301351T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/626,857 US7022340B2 (en) 2003-07-25 2003-07-25 Pharmaceutical composition as solid dosage form and method for manufacturing thereof
EP03016945A EP1500390B1 (de) 2003-07-25 2003-07-25 Pharmazeutische Desmopressin-Zubereitung als feste Darreichungsform und Methode zu ihrer Herstellung

Publications (2)

Publication Number Publication Date
DE60301351D1 true DE60301351D1 (de) 2005-09-22
DE60301351T2 DE60301351T2 (de) 2006-01-19

Family

ID=34117527

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60301351T Expired - Lifetime DE60301351T2 (de) 2003-07-25 2003-07-25 Pharmazeutische Desmopressin-Zubereitung als feste Darreichungsform und Methode zu ihrer Herstellung

Country Status (22)

Country Link
US (1) US7022340B2 (de)
EP (1) EP1500390B1 (de)
JP (1) JP4430673B2 (de)
KR (1) KR20050104331A (de)
AT (1) ATE301990T1 (de)
AU (1) AU2004260625B2 (de)
BR (1) BRPI0412905A (de)
CA (1) CA2490335C (de)
DE (1) DE60301351T2 (de)
DK (1) DK1500390T3 (de)
ES (1) ES2243840T3 (de)
HK (1) HK1072009A1 (de)
IL (1) IL187591A0 (de)
MX (1) MXPA06000903A (de)
NO (1) NO327328B1 (de)
NZ (1) NZ544104A (de)
PL (1) PL379704A1 (de)
PT (1) PT1500390E (de)
RU (1) RU2303439C2 (de)
SI (1) SI1500390T1 (de)
TW (1) TWI268782B (de)
WO (1) WO2005011640A2 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0210397D0 (en) 2002-05-07 2002-06-12 Ferring Bv Pharmaceutical formulations
US7094545B2 (en) * 2003-04-30 2006-08-22 Ferring Bv Pharmaceutical composition as solid dosage form and method for manufacturing thereof
CN1826099B (zh) * 2003-07-25 2010-06-09 凡林有限公司 固体剂型药物组合物及其制造方法
ES2260563T3 (es) * 2003-11-13 2006-11-01 Ferring B.V. Paquete de blister y forma farmaceutica solida para ello.
US7018653B2 (en) * 2003-12-29 2006-03-28 Ferring B.V. Method for preparing solid dosage form of desmopressin
CA2490601C (en) * 2003-12-29 2006-05-02 Ferring B.V. Method for preparing solid dosage form of desmopressin
SE528446C2 (sv) * 2006-03-02 2006-11-14 Ferring Int Ct Sa Farmaceutisk sammansättning innefattande desmopressin, kiseldioxid och stärkelse
CA2695634C (en) 2007-08-06 2018-01-23 Serenity Pharmaceuticals Corporation Methods and devices for desmopressin drug delivery
ES2319054B1 (es) 2007-08-06 2010-02-12 Gp Pharm S.A. Composicion farmaceutica oral de desmopresina.
US20090232896A1 (en) * 2008-03-11 2009-09-17 Mallinckrodt Inc. Use of Magnesium Stearate Dihydrate for Lubrication of Solid Pharmaceutical Compositions
US11963995B2 (en) 2008-05-21 2024-04-23 Ferring B.V. Methods comprising desmopressin
DK3225250T3 (da) * 2008-05-21 2019-11-04 Ferring Bv Orodispersibel desmopressin til forlængelse af den indledende søvnperiode, som ikke forstyrres af nykturi
US20100286045A1 (en) 2008-05-21 2010-11-11 Bjarke Mirner Klein Methods comprising desmopressin
KR20110089265A (ko) * 2008-09-30 2011-08-05 미쓰이 가가쿠 가부시키가이샤 섬유 강화 수지 조성물 및 그의 성형체

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8306367L (sv) * 1983-11-18 1985-05-19 Ferring Ab Antidiuretiskt verkande farmaceutiskt preparat
US4675188A (en) * 1985-08-02 1987-06-23 Stauffer Chemical Company Granular anhydrous dicalcium phosphate compositions suitable for direct compression tableting
US4820627A (en) * 1986-03-24 1989-04-11 Em Diagnostic Systems, Inc. Method of preparing particles suitable for tabletting into diagnostic reagents
US5482931A (en) 1993-06-29 1996-01-09 Ferring Ab Stabilized pharmaceutical peptide compositions
WO1995018602A1 (en) 1994-01-11 1995-07-13 Alkermes Controlled Therapeutics, Inc. ORAL DOSAGE FORM OF DESMOPRESSIN (dDAVP)
SE9400918L (sv) 1994-03-18 1995-09-19 Anne Fjellstad Paulsen Stabiliserad komposition för oral administrering av peptider
US5849322A (en) 1995-10-23 1998-12-15 Theratech, Inc. Compositions and methods for buccal delivery of pharmaceutical agents
GB9526495D0 (en) 1995-12-23 1996-02-28 Knoll Ag Therapeutic agents
DE19602757A1 (de) * 1996-01-26 1997-07-31 Boehringer Mannheim Gmbh Feste Instant-Release-Darreichungsformen und Verfahren zu ihrer Herstellung
WO2000009423A1 (es) 1998-08-11 2000-02-24 Jaime Marti Sala Silo para almacenamiento de cuerpos huecos ligeros
AT409081B (de) 2000-02-16 2002-05-27 Gebro Pharma Gmbh Stabile, nasal, oral oder sublingual anwendbare pharmazeutische zubereitung
WO2001078696A2 (en) 2000-04-17 2001-10-25 Vectura Limited Formulations for use in inhaler devices
GB0009469D0 (en) * 2000-04-17 2000-06-07 Vectura Ltd Improvements in or relating to formalities for use in inhaler devices
PE20011227A1 (es) * 2000-04-17 2002-01-07 Chiesi Farma Spa Formulaciones farmaceuticas para inhaladores de polvo seco en la forma de aglomerados duros
GB0010709D0 (en) 2000-05-03 2000-06-28 Vectura Ltd Powders for use a in dry powder inhaler
WO2002000197A1 (en) 2000-06-27 2002-01-03 Vectura Limited Method of making particles for use in a pharmaceutical composition
PL367957A1 (en) 2001-10-15 2005-03-07 Röhm Gmbh & Co.Kg Use of a copolymer to produce a galenic form containing a peptide or a protein as active agent
DE60307082D1 (de) 2002-05-07 2006-09-07 Ferring Bv In der mundhöhle dispergierbare phamarzeutische zusammensetzung mit desmopressin
EP1473029B1 (de) * 2003-04-30 2005-03-23 Ferring B.V. Feste Dosierungsform mit Desmopressin
US7094545B2 (en) * 2003-04-30 2006-08-22 Ferring Bv Pharmaceutical composition as solid dosage form and method for manufacturing thereof

Also Published As

Publication number Publication date
TW200509995A (en) 2005-03-16
CA2490335A1 (en) 2005-01-25
EP1500390B1 (de) 2005-08-17
NZ544104A (en) 2008-06-30
WO2005011640A2 (en) 2005-02-10
KR20050104331A (ko) 2005-11-02
RU2303439C2 (ru) 2007-07-27
ATE301990T1 (de) 2005-09-15
BRPI0412905A (pt) 2006-09-26
IL187591A0 (en) 2008-03-20
MXPA06000903A (es) 2006-05-04
US7022340B2 (en) 2006-04-04
PL379704A1 (pl) 2006-11-13
DE60301351T2 (de) 2006-01-19
AU2004260625A1 (en) 2005-02-10
NO20051896L (no) 2005-04-19
PT1500390E (pt) 2005-10-31
EP1500390A1 (de) 2005-01-26
SI1500390T1 (sl) 2006-02-28
RU2005141230A (ru) 2006-07-10
ES2243840T3 (es) 2005-12-01
CA2490335C (en) 2006-01-31
WO2005011640A3 (en) 2005-03-24
US20050019392A1 (en) 2005-01-27
AU2004260625B2 (en) 2007-12-06
HK1072009A1 (en) 2005-08-12
NO327328B1 (no) 2009-06-08
TWI268782B (en) 2006-12-21
JP2007517762A (ja) 2007-07-05
JP4430673B2 (ja) 2010-03-10
DK1500390T3 (da) 2005-09-19

Similar Documents

Publication Publication Date Title
NO20051896L (no) Farmasoytisk sammensetning som fast doseringsform samt fremgangsmate for fremstilling derav
WO2003082853A8 (en) New compounds
EP2283826A3 (de) Galenische Formulierungen mit organischen Verbindungen
EA200500891A1 (ru) Фармацевтические композиции, содержащие щелочные или соответственно кислые лекарственные соединения, поверхностно-активное вещество и физиологически приемлемую водорастворимую кислоту или соответственно основание
UA85708C2 (ru) Лекарственные комбинации, содержащие бензоксазины, для лечения заболеваний дыхательных путей
DE60212734D1 (de) Pharmazeutische Zubereitung enthaltend Doxazosin
WO2006024486A3 (en) Amide derivatives of 3-phenyl dihydropyrimido[4,5-d]pyrimidinones, their manufacture and use as pharmaceutical agents
TW200518743A (en) Rapid dissolution formulation of a calcium receptor-active compound
WO2003048164A3 (en) Adenosine a2a receptor antagonists
TW200606164A (en) New compounds
TW200505823A (en) CaSR antagonist
TW200640465A (en) New pharmaceutically active compounds for the treatment of respiratory diseases
ATE329581T1 (de) Pharmazeutische formulierung, die n-((1-n-butyl-4-piperidinyl)menthyl)-3,4-dihydr -2h-(1, 3)oxazino(3,2-a)indol-10-carboxamid oder ein entsprechendes salz hiervon enthält, sowie deren herstellungsprozess, welcher trockengranulierung beinhaltet
SE0102440D0 (sv) New compound
FR2819720B1 (fr) Nouveaux comprimes de fenofibrate
WO2003037916A3 (en) Linear basic compounds having nk-2 antagonist activity and formulations thereof
BE2016C017I2 (de)
SE0000303D0 (sv) Novel compounds
CA2486833A1 (en) Solid dosage form comprising desmopressin and method for manufacturing thereof
CA2423288A1 (en) New pharmaceutical compositions containing epinastine and pseudoephedrine
EA200400864A1 (ru) ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ, СОДЕРЖАЩИЕ 2-(4-ЭТОКСИФЕНИЛ)-3-(4-МЕТАНСУЛЬФОНИЛФЕНИЛ)ПИРАЗОЛО[1,5-b]ПИРИДАЗИН В ФОРМЕ НАНОЧАСТИЦ
WO2001053322A3 (en) Aerothricin analogs, their preparation and use
AR046261A1 (es) Composicion farmaceutica como forma de dosificacion solida y metodo para su fabricacion

Legal Events

Date Code Title Description
8363 Opposition against the patent